NCT06860269
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06860269
Title A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia (GRAALL-2024)
Acronym GRAALL-2024
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Assistance Publique - Hôpitaux de Paris
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Hôpital Saint Louis RECRUITING Paris France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field